(HealthDay)—For HIV-infected patients, a one-month regimen of rifapentine and isoniazid is noninferior to nine months of isoniazid alone for preventing
One-month regimen noninferior for preventing HIV-related TB
Home »
Green light therapy moves to next phase of study: HIV-related pain
After proving surprisingly beneficial in human clinical trials at the University of Arizona for the treatment of pain resulting from